# Tesamorelin: a signal, a specific indication

- Falutz et al. · Original randomized trial · NEJM 2007
  https://pubmed.ncbi.nlm.nih.gov/18057338/

- Original article · DOI 10.1056/NEJMoa072375
  https://doi.org/10.1056/NEJMoa072375

- FDA · Original Egrifta approval · November 10, 2010
  https://www.accessdata.fda.gov/drugsatfda_docs/nda/2010/022505Orig1s000Approv.pdf

- FDA · Egrifta WR prescribing information · March 2025
  https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/022505s020lbl.pdf

- DailyMed · Egrifta WR label repository
  https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=839334d3-8c1d-4c26-9036-2ab524a6ea75

- Theratechnologies · Company development account
  https://www.theratech.com/about/overview/